최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기大韓韓方小兒科學會誌 = The journal of pediatrics of Korean medicine, v.30 no.3, 2016년, pp.1 - 30
이진화 (대전대학교 한의과대학 소아과학교실) , 한재경 (대전대학교 한의과대학 소아과학교실) , 김윤희 (대전대학교 한의과대학 소아과학교실)
Objectives Previous studies have found out that Forsythiae Fructus (FF) extracts have anti-atopic activities by in vitro experiment. In order to understand more about FF extracts' benefit, we subdivided FF extracts depending on systematic fractionation method by using Methylene chloride (MC), Ethyl ...
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
아토피 피부염이란? | 아토피 피부염은 유 · 소아에 흔히 발생하는 소양감과 전형적인 피부염증 반응을 주증상으로 하는 만성 재발성 피부 염증질환이다1). 아토피 피부염의 원인은 아직 정확하게 밝혀지지 않았으나2) IgE 합성과 호산구 증가와 함께 T세포 면역반응에서 Th1 반응에 비해 Th2 반응이 우세하여 발생된 불균형이 핵심적인 면역학적 원인으로 보고되고 있다3-4). | |
아토피 피부염의 원인은? | 아토피 피부염은 유 · 소아에 흔히 발생하는 소양감과 전형적인 피부염증 반응을 주증상으로 하는 만성 재발성 피부 염증질환이다1). 아토피 피부염의 원인은 아직 정확하게 밝혀지지 않았으나2) IgE 합성과 호산구 증가와 함께 T세포 면역반응에서 Th1 반응에 비해 Th2 반응이 우세하여 발생된 불균형이 핵심적인 면역학적 원인으로 보고되고 있다3-4). Th2 세포가 분비하는 IL-4, IL-5, IL-6, IL-9, IL-10, IL-13, TNF-α 등의 일련의 사이토카인 중 IL-4와 IL-13은 B세포의 IgE 생성을 유도하고, IL-5는 호산구의 분화와 성숙 및 분비에 관여 하여 즉시형 아토피 반응을 유발한다5-6). | |
즉시형 아토피가 유발되는 Th1 반응 보다 Th2 반응이 우세하게 되는 과정은? | 아토피 피부염의 원인은 아직 정확하게 밝혀지지 않았으나2) IgE 합성과 호산구 증가와 함께 T세포 면역반응에서 Th1 반응에 비해 Th2 반응이 우세하여 발생된 불균형이 핵심적인 면역학적 원인으로 보고되고 있다3-4). Th2 세포가 분비하는 IL-4, IL-5, IL-6, IL-9, IL-10, IL-13, TNF-α 등의 일련의 사이토카인 중 IL-4와 IL-13은 B세포의 IgE 생성을 유도하고, IL-5는 호산구의 분화와 성숙 및 분비에 관여 하여 즉시형 아토피 반응을 유발한다5-6). 또한 IL-4, IL-5, IL-13 등의 사이토카인은 염증반응을 확장시켜 Th2 세포 반응을 우세하게 만드는 양성 되먹임 작용을 일으킨다6-7) |
Ahn HS. Hongchangui pediatrics, 9th edition, Seoul: Miraen. 2010:1142.
Park YM. Advances in the pathophysiology of atopic dermatitis. Pediatr Allergy Respir Dis. 2006;16(3):189-96.
Mudde GC, Reijsen FC, Boland GJ, Bruijnzeel PL, Bruijnzeel-K. Allergen presentation by epidermal Langerhans' cells from patients with atopic dermatitis is mediated by IgE. Immunol. 1990;69(3):335-41.
Markus G, Carla A, Bruijnzeel-K, Erwin S, Theo T, Alice G. Langeveld-W, Thomas R, Jean K. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol. 1998;19(8):359-61.
Reijsena FC, Bruijnzeel-K, Kalthoff F,. Maggi E, Romagnani S, Westlanda J, Mudde GC. Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis. J Allergy Clin Immunol. 1992;90(2):184-93.
Foster PS, Martinez-Moczygemba M, Huston DP, Corry DB. Interleukins -4, -5, and -13; emerging therapeutic targets in allergic disease. Pharmacol Ther. 2002;94(3): 253-624.
Matsubara M, Masaki S, Ohmori K, Karasawa A, Hasegawa K. Differential regulation of IL-4 expression and degranulation by anti-allergic olopatadine in rat basophilic leukemia (RBL-2H3) cells. Biochem Pharmacol. 2004;67(7):1315-26.
Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol. 1980;92:44-7.
Yoon JH, Bae JH, Difficulties and needs of parents raising young children with atopic dermatitis. Eco-Early Child Edu. 2013;12(1):113-37.
Harri A, Marie-C, Stephan M, Juliane R, Martin S, Thomas K, Hoffmann, Thomas R, Albert Z, Bernhard H. IL-31: A new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol. 2006;177(2):411-7.
Kim S, Kim HJ, Yang HS, Kim EG, Huh IS, Yang JM. IL-31 serum protein and tissue mRNA levels in patients with atopic dermatitis. Ann Dermatol. 2011; 23(4):468-73.
Ulrike R, Katja W, Manuela B, Sonja S, Bettina W, Alexander K, Thomas W. Correlation of IL-31 serum levels with severity of atopic dermatitis. J Allergy Clin Immunol. 2006;122(2):421-3.
Grimstad Q, Sawanobori Y, Vestergaard C, Bilsborough J, Olsen UB, Larsen C, Matsushima K. Anti interleukin 31 antibodies ameliorate scratching behaviour in NC/Nga mice; a model of atopic dermatitis. Experiment Dermatol. 2009;18(1):35-43.
Ju YS. Ungok herbology. Jeonju: Woosuk Press. 2013:494-7.
Herbology Association of Korea's Colleges of Oriental Medicine. Textbook of herbology, 1st ed. Seoul: Younglimsa. 1991:199.
Nam JB, Lee MH, Choi HY, Sohn NW, Kang H. Effect of Forsythiae Fructus ethanol extract on inflammatory cytokine production and cellular signaling pathways in mouse macrophages. Korean J Herbol. 2012;27(1):59-64.
Kim SY, Park YK. Ethanol extract of Forsythiae Fructus inhibits the production of inflammatory mediators in LPS-stimulated BV-2 microglial cells. Korean J Herbol. 2008;23(3):93-102.
Lee JM, Choi SW, Cho SH, Phee SJ. Effect of Forsythia Viridissima extracts on antiosidative system and lipid peroxidation of liver in rats fed high-cholesterol die. Koran J Nutr Health. 2003;36(10):990-6.
Jung YJ, Jeon YS, Kim HJ, Kang SK, Kim YK, Kim NS. Anti-allergic and anti-inflammatory effect of Leonurus Sibiricus seed ethyl acetate fractions. Yakhak Hoeji. 2014;58(5):294-9.
Yang CH, Lee YM, Cho KY, Bae KH, Chung CP. Effect of Zizyphi Fructus extract on the biological activity of Gingival Fibroblast. J Korean Periodontol. 1994; 24(1):144-54.
Kim JH. Recent advances in atopic dermatitis. Allergy Asthma Respir Dis. 2004;14(1):12-23.
Kim CH, Lee SI, Lee SY, Choi SY, Lee JS, Kim KE. Nationwide study for epidemiological change of atopic dermatitis in school aged children between 1995 and 2000 and kindergarten aged children in 2003 in Korea. Allergy Asthma Respir Dis. 2003;13(4):227-37.
Greer FR, Sicherer SH, Burks AW. Effect of early nutritional interventions on the development of atopic disease in infants and children; the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas. Pediatr. 2008;111:608-16.
Vander H, Klip H, Brand PI. Risk of developing asthma in young children with atopic eczema; a systemic review. J Allegy Clin Immunol. 2007;120:565-9.
Lee JH, Kim KH, Kim MN, Kim JW, No YS, Park YL, Park CW, Lee KH, Lee AY, Jo SH, Choi JH. The treatment guideline of Korean atopic dermatitis. Korean J Dermatol. 2006;44(8):907-13.
Katayama I, Kohno Y, Akiyama K, Ikezawa Z, Kondo N, Tamaki K, Kouro O. Japanese guideline for atopic dermatitis. Allergol Int. 2011;60:205-20.
Schacke H, Docke WD, Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther. 2002;96:23-43.
Dowell SF, Bresee JS. Severe varicella associated with steroid use. Pediatr. 1993;92:223-8.
Kim SC, Ahn KJ, Hann SK, Kim JW, Sung KJ, Kye YC, Kim NI, Cho KH, Kim KJ, Youn JI. Clinico-epidemiologic study on the abuse, misuse, and adverse effects of topical dermatologic drugs. Korean J Dermatol. 2003;41(9):1129-35.
Jin HW, Jang HS, Jang BS, Jo JH, Kim MB, Oh CG, Gwon KS, Gwon YY. The use of alternative medicine and management in children with atopic dermatitis. Korean J Dermatol. 2005;43(7):903-11.
Kim SH. The use of oriental and complementary alternative medicine in children with atopic dermatitis. University Master of Cha Medical University. 2007.
Koh DJ, You HJ, Lee JY, Kim DG. Clinical assessment of efficacy, safety and usefulness of traditional herbal medicine (THM) on atopic dermatitis. J Korean Orient Pediatr. 2006;20(2);129-37.
Schulz F, Marenholz I, Foster-Holst R, Chen C, Sternjak A, Baumgrass R. A common haplotype of the IL-31 gene influencing gene expression is associated with nonatopic eczema. J Allergy Clin Immunol. 2007;120: 1097-102.
Zhang Q, Prabhakar P, Zhou Q, Liu QS, Gao WD. Structures and biological functions of IL-31 and IL-31 receptors. Cytokine Growth Factor Rev. 2008; 19(2008):347-56.
Cornelissen C, Luscher-Firzlaff J, Baron JM, Luschera B. Signaling by IL-31 and functional consequences. Eur J Cell Biol. 2011;91(2012):552-66.
Ha NL, Lee JC, Kim KB. Recent research on treatments of atopic dermatitis in Japan. Diet Kampo Med. 2012;26(1):16-35.
Yoon JY, Han JK, Kim YH. Effect of Kami-chungsimyeunjatang on atopic dermatitis-like skin lesions induced in NC/Nga mice by mite antigen stimulation. J Korean Orient Pediatr. 2007;21(1):87-116.
Yeo EJ, Han JK, Kim YH. Inhibitory studies of Scrophulariae Radix on development of dermatitis in NC/Nga mice. J Korean Orient Pediatr. 2007;21(2): 13-34.
Liebmann C. Regulation of MAP kinase activity by peptide receptor signalling pathway; paradigms of multiplicity. Cell Signal. 2001;13:777-85.
Whitmarsh AJ, Davis RJ. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med. 1996;74:589-607.
Lewin I, Nechushtan H, Ke Q, Razin E. Regulation of AP-1 expression and activity in antigen-stimulated mast cells; the role played by protein kinase C and the possible involvement of Fos interacting protein. Blood. 1993;82:3745-51.
Yun YG, Hwang JM, Kim HR, Jang SU. Mouse models of atopic dermatitis for drug discovery from medicinal plants. Korean J Orient Med Prescription. 2007;150: 145-61.
Venkayya R, Lam M, Willkom M, Grunig G, Corry DB, Erle DJ. The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells. Am J Respir Cell Mol Biol. 2002;26:202-8.
Kim HM, Eom JY, Jeong HJ, Hong SH. Immune and allergic. Seoul: Shinil Books. 2008:168, 171, 222.
Humbert M, Grant JA, Taborda-Barata L, Durham SR, Pfister R, Menz G. High-affinity IgE receptor (Fcepsiolon RI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma. Am J Respir Crit Care Med. 1996;153:1931-7.
Toru H, Pawankar R, Ra C, Yata J, Nakahata T. Human mast cells produce IL-13 by high-affinity IgE receptor cross-linking; enhanced IL-13 production by IL-4-primed human mast cells. J Allergy Clin Immunol. 1998;102(3): 491-502.
Kim JW. Atopic dermatitis at allergic and immunological aspects. J Korean Dermatol Assoc. 2003;41(6): 687-9.
Abbas Abul K, Lichtman Andrew H, Pillai Shiv. Cellular and Molecular Immunology 6th ed. Philadelphia: Saunders. 2007:304-15.
Mehrotra PT, Wu D, Crim JA, Mostowski HS, Siegel JP. Effects of IL-12 on the generation of cytotoxic activity in human CD8+ T lymphocytes. J Immunol. 1993; 151(5):2444-52.
Zdolsek HA, Ernerudh J, Holt PG, Nilsson J, Bjorksten B. Expression of the T-cell markers CD3, CD4 and CD8 in healthy and atopic children during the first 18 months of life. Arch Allergy Immunol. 1999; 119:6-12.
Kim SJ. Immunology 1st ed. Seoul: Koryo medicine. 1994:150-3, 206.
Rich Robert R, Fleisher Thomas T, Shearer William T, Schroeder H. Clinical immunology. New York: Mosby. 2001;chap4:13, chap6:18.
Dorshkind K, Narayanan R, Landreth KS. Regulatory cells and cytokines involved in primary B lymphocyte production. Adv Exp Med Biol. 1992;323:119-23.
Askenasea Philip W, Kawikovaa I, Paliwala V, Akahira-Azumaa M, Gerardc C, Huglib T, Tsujid. A new paradigm of T cell allergy; requirement for the B-1 cell subset. Int Arch Allergy Immunol. 1999;118: 145-9.
Bronte V, Wang M, Overwijk WW, Surman DR, Pericle F, Rosenberg SA, Restifo NP. Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+cells. J Immunol. 1998;161(10):5313-20.
Angulo I, Heras FG, Garcia-Bustos JF, Gargallo D, Munoz-Fernandez A, Fresno M. Nitric oxide-producing CD11b (+)Ly- 6G (Gr-1) (+)CD31 (ER-MP12) (+) cells in the spleen of cyclophosphamide- treated mice: implications for T-cell responses in immuno-suppressed mice. Blood. 2000;95(1):212-20.
Park EH, Yoo JH, Gim SB, Lee YK, Kim DH. Effect of Hyunggaeyunkyotangbalhyobang (HYBH) on atopic dermatitis in NC/Nga mice model. J Orient Med Daejeon University. 2011;19(2):65-83.
Han DS, Han JK, Kim YH, Effects of SPDJTK (SoPungDoJeokTangKami) and concurrent administration of AJ (Atopy cream, Jawoongo) plus SPDJTK on atopic dermatitis-like skin lesions in NC/Nga mouse induced by BMAC. J Korean Orient Pediatr. 2010;24(1): 9-35.
Lee YS, Han JK, Kim YH, The effects of Dictamni Radicis cortex extracts on dncb induced atopic dermatitis-like skin lesions of NC/Nga mouse. J Pediatr Korean Med. 2014;28(4):1-29.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.